Black cohosh (Cimicifuga spp.) for menopausal symptoms

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Leach, Matthew J ^a   Moore, Vivienne ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT;

BONE DENSITY; CIMICIFUGA RACEMOSA; CLIMACTERIUM; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; GASTROINTESTINAL SYMPTOM; HEPATITIS; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYPERTENSION; MENOPAUSAL SYNDROME; META ANALYSIS; MORBIDITY; NIGHT SWEAT; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PLANT STEM; POSTMENOPAUSE; QUALITY OF LIFE; RASH; REVIEW; RHIZOME; SEXUAL HEALTH; SYSTEMATIC REVIEW; THROMBOSIS; TREATMENT DURATION; VAGINAL DRYNESS;

EID: 55049111173     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007244     Document Type: Review

References (17)

1. ADEC 2004 Australian Drug Evaluation Committee (ADEC). ADEC summary statement on HRT. Canberra: Therapeutic Goods Administration, 2004.
2. Blumenthal 2003 Blumenthal M. The ABC clinical guide to herbs. Austin: American Botanical Council, 2003.
3. Borelli 2003 Borelli F, Izzo AA, Ernst E. Pharmacological effects of Cimicifuga racemosa. Life Sciences 2003;73(10):1215-29.
4. Corwin 2008 Corwin EJ. Handbook of pathophysiology. Philadelphia: Lippincott, Williams & Wilkins, 2008.
5. Farquhar 2005 Farquhar CM, Marjoribanks J, Lethaby A, Lamberts Q, Suckling JA, Cochrane HT Study Group. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database of Systematic Reviews 2005, Issue 3. [DOI: 10.1002/14651858.CD004143.pub2.]
6. Gabriel-Sánchez 2005 Gabriel-Sánchez R, Carmona L, Roque M, Sánchez-Gómez LM, Bonfill X. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women. CochraneDatabase of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD002229.pub2]
7. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine 2002;21:1539-58.
8. Higgins 2008 Higgins JPT, Green S. (eds). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated 2008]. The Cochrane Library. Chichester, UK: John Wiley & Sons, Ltd, 2008, issue 3.
9. Huntley 2003 Huntley A, Ernst E. A systematic review of the safety of black cohosh. Menopause 2003;10(1):58-64.
10. Keville 1991 Keville K. The illustrated herb encyclopedia. East Roseville: Simon & Shuster Australia, 1991.
11. MacLennan 2004 MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD002978.pub2]
12. McKinlay 1992 McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. American Journal of Human Biology 1992;4(1):37-46.
13. Mills 2000 Mills S, Bone K. Principles and practice of phytotherapy: modern herbal medicine. Edinburgh: Churchill Livingstone, 2000.
14. Mishra 2006 Mishra G, Kuh D. Perceived change in quality of life during the menopause. Social Science & Medicine 2006;62(1):93- 102.
15. Peeyananjarassr 2005 Peeyananjarassri K, Baber R. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric 2005;8(1):13-23.
16. Porter 2007 Porter RS, Kaplan JL. The Merckmanual online. Whitehouse Station, New Jersey: Merck Research Laboratories, 2007.
17. Rossouw 2002 Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women. Journal of the American Medical Association 2002;288(3):321-33.